Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,449
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,872
Class I recallsReasonable probability of serious health consequences
24,509
Class II recallsTemporary or medically reversible health consequences
2,932
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,096 recalls
Most affected stateHawaii 200 recalls mention this state

Advertisement

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,956 recalls have been announced year to date.
  • Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
  • The highest complete period was Jun 2026 (300).
  • Nov 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,509
Class I9,872
Class III2,932
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,509
Class I9,872
Class III2,932
Not Yet Classified2

Showing 12,261–12,280 of 21,307 recalls

FDA Recall TerminatedTerminated: January 30, 2020Historical recordClass II

Methyl-Cobalamin injectable, 1 mg/mL, packaged in a) 5 mL and b) 30 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 30, 2020Historical recordClass II

Glutathione injectable, 200 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 30, 2020Historical recordClass II

Dexpanthenol injectable, 250 mg/mL, 10 mL Single Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 30, 2020Historical recordClass II

Calcium Gluconate injectable, 10%, 50 ml Single Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 30, 2020Historical recordClass II

CoEnzyme-Q10 injectable, 20 mg/mL, 10 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

by Auro Pharmacies, Inc.

Reason
Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 18, 2022Historical recordClass II

Ipamorelin 9 mg vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 18, 2022Historical recordClass II

Methylcobalamin 10 mg vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 18, 2022Historical recordClass II

Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 18, 2022Historical recordClass II

Human Chorionic Gonadotropin 6000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 18, 2022Historical recordClass II

Human Chorionic Gonadotropin 4000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 18, 2022Historical recordClass II

Human Chorionic Gonadotropin 2500 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 18, 2022Historical recordClass II

Human Chorionic Gonadotropin 20000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 18, 2022Historical recordClass II

Human Chorionic Gonadotropin 11000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 18, 2022Historical recordClass II

Human Chorionic Gonadotropin 5000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009

by Pharmcore Inc.

Reason
Lack of assurance of sterility.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP, 5 mg/160 mg/25 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-329-30

by Torrent Pharma Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP, 10 mg/160 mg/25 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-328-30

by Torrent Pharma Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP, 10 mg/160 mg/12.5 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-327-30

by Torrent Pharma Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP, 5 mg/160 mg/12.5 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-326-30

by Torrent Pharma Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP, 10 mg/320 mg/25 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-325-30

by Torrent Pharma Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Amlodipine and Valsartan Tablets, USP, 5 mg/160 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-207-30

by Torrent Pharma Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.